Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
Clinical trial NCT00441350 · COMPLETED
Trial details
- NCT number
- NCT00441350
- Sponsor
- Menarini Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2008-05-01
- Enrollment
- 1004
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.